- RecruitingPHASE2
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
This study is testing a new cream called delgocitinib for adults with palmoplantar pustulosis (PPP), a skin condition causing pus-filled spots on hands and feet. Researchers want to see if the cream is safe and helps improve PPP over 16 weeks.
For: Palmoplantar PustulosisUnited States · Canada · Germany - RecruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
This study is looking at a cream called ruxolitinib for children aged 6 to 11 with a skin condition called nonsegmental vitiligo. Researchers want to see how well it works to reduce white patches and if it's safe to use.
For: NonSegmental VitiligoArgentina · Austria · Belgium - Active not recruitingPHASE3
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
This study is testing a new cream called Ruxolitinib for children and teenagers aged 6 to 17 who have moderate eczema (atopic dermatitis). We want to see if it's safe and effective at reducing their skin symptoms. There's also a 'dummy' cream for comparison.
For: Atopic DermatitisUnited States · Belgium · Canada - RecruitingPHASE3
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
This study is looking at a new cream called tapinarof to treat eczema in babies and toddlers aged 3 months to under 2 years old. Researchers want to see if it's safe and helps improve their eczema compared to a cream without any medicine.
For: Atopic DermatitisUnited States · Canada - RecruitingPHASE3
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
This study is looking at a cream for hidradenitis suppurativa (HS), a skin condition. It aims to see how well ruxolitinib cream works and if it's safe for people with mild to moderate HS. Some people will get the cream, others a 'dummy' cream.
For: Hidradenitis SuppurativaUnited States · Bulgaria · Canada